Characterization of two plasmid-encoded cefotaximases found in clinical Escherichia coli isolates: CTX-M-65 and a novel enzyme, CTX-M-87

Journal of Medical Microbiology

Volumn 58, Issue 6, 2009, Pages 811-815

  Yin, Jun ^a   Cheng, Jun ^a   Sun, Zhen ^a   Ye, Ying ^a   Gao, Yu Feng ^a   Li, Jia Bin ^a   Zhang, Xue Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; ENZYME CTX M 14; ENZYME CTX M 65; ENZYME CTX M 87; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFOTAXIME; CHINA; CLONING, MOLECULAR; CONJUGATION, GENETIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PLASMIDS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 66449130688     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.006007-0     Document Type: Article

References (32)

1. Ambler, R. P., Coulson, A. F., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G. & Waley, S. G. (1991). A standard numbering scheme for the class A beta-lactamases. Biochem J 276, 269-270.
2. Babic, M., Hujer, A. M. & Bonomo, R. A. (2006). What's new in antibiotic resistance? Focus on beta-lactamases. Drug Resist Updat 9, 142-156. (Pubitemid 44279523)
3. Bae, I. K., Lee, B. H., Hwang, H. Y., Jeong, S. H., Hong, S. G., Chang, C. L., Kwak, H. S., Kim, H. J. & Youn, H. (2006). A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop. J Antimicrob Chemother 58, 315-319. (Pubitemid 44294941)
4. Barthélémy, M., Péduzzi, J., Bernard, H., Tancrède, C. & Labia, R. (1992). Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum beta-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochim Biophys Acta 1122, 15-22.
5. Bauernfeind, A., Grimm, H. & Schweighart, S. (1990). A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18, 294-298. (Pubitemid 20349311)
6. Bonnet, R. (2004). Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1-14. (Pubitemid 38040170)
7. Bonnet, R., Dutour, C., Sampaio, J. L., Chanal, C., Sirot, D., Labia, R., De Champs, C. & Sirot, J. (2001). Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob Agents Chemother 45, 2269-2275. (Pubitemid 32664466)
8. Bradford, P. A., Yang, Y., Sahm, D., Grope, I., Gardovska, D. & Storch, G. (1998). CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob Agents Chemother 42, 1980-1984. (Pubitemid 28363079)
9. Bush, K. (2001). New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32, 1085-1089. (Pubitemid 32299644)
10. Chanawong, A., M'Zali, F. H., Heritage, J., Xiong, J. H. & Hawkey, P. M. (2002). Three cefotaximases, CTX-M-9, CTX-M-13, and CTXM-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 46, 630-637. (Pubitemid 34157644)
11. Cheng, J., Ye, Y., Wang, Y. Y., Li, H., Li, X. & Li, J. B. (2008). Phenotypic and molecular characterization of 5 novel CTX-M enzymes carried by Klebsiella pneumoniae and Escherichia coli. Acta Pharmacol Sin 29, 217-225.
12. CLSI (2007). Performance Standards for Antimicrobial Susceptibility Testing; 16th Informational Supplement. M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute.
13. Delmas, J., Robin, F., Carvalho, F., Mongaret, C. & Bonnet, R. (2006). Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9. Antimicrob Agents Chemother 50, 731-738. (Pubitemid 43190989)
14. Doi, Y., Adams-Haduch, J. M. & Paterson, D. L. (2008). Escherichia coli isolate coproducing 16S rRNA methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States. Antimicrob Agents Chemother 52, 1204-1205.
15. Gautom, R. K. (1997). Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol 35, 2977-2980.
16. Gazouli, M. & Legakis, N. J. (1998). Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A beta-lactamase CTXM-4. FEMS Microbiol Lett 169, 289-293. (Pubitemid 29050792)
17. Gazouli, M., Tzelepi, E., Markogiannakis, A., Legakis, N. J. & Tzouvelekis, L. S. (1998a). Two novel plasmid-mediated cefotaxime-hydrolyzing beta-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium. FEMS Microbiol Lett 165, 289-293. (Pubitemid 29090307)
18. Gazouli, M., Tzelepi, E., Sidorenko, S. V. & Tzouvelekis, L. S. (1998b). Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis. Antimicrob Agents Chemother 42, 1259-1262. (Pubitemid 28227932)
19. Gniadkowski, M., Schneider, I., Pałucha, A., Jungwirth, R., Mikiewicz, B. & Bauernfeind, A. (1998). Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother 42, 827-832. (Pubitemid 28216362)
20. Ishii, Y., Ohno, A., Taguchi, H., Imajo, S., Ishiguro, M. & Matsuzawa, H. (1995). Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 39, 2269-2275.
21. Karisik, E., Ellington, M. J., Pike, R., Livermore, D. M. & Woodford, N. (2006). Development of high-level ceftazidime resistance via single-base substitutions of blaCTX-M-3 in hyper-mutable Escherichia coli. Clin Microbiol Infect 12, 803-806. (Pubitemid 43983809)
22. Kimura, S., Ishiguro, M., Ishii, Y., Alba, J. & Yamaguchi, K. (2004). Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis. Antimicrob Agents Chemother 48, 1454-1460. (Pubitemid 38544346)
23. Kimura, S., Ishii, Y., Tateda, K. & Yamaguchi, K. (2007). Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167. Int J Antimicrob Agents 29, 326-331. (Pubitemid 46240743)
24. Ma, L., Ishii, Y., Ishiguro, M., Matsuzawa, H. & Yamaguchi, K. (1998). Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam. Antimicrob Agents Chemother 42, 1181-1186. (Pubitemid 28227917)
25. Ma, L., Ishii, Y., Chang, F. Y., Yamaguchi, K., Ho, M. & Siu, L. K. (2002). CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 46, 1985-1988. (Pubitemid 34535227)
26. Mugnaioli, C., Luzzaro, F., De Luca, F., Brigante, G., Perilli, M., Amicosante, G., Stefani, S., Toniolo, A. & Rossolini, G. M. (2006). CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 50, 2700-2706. (Pubitemid 44198690)
27. Mulvey, M. R., Bryce, E., Boyd, D., Ofner-Agostini, M., Christianson, S., Simor, A. E., Paton, S. & The Canadian Hospital Epidemiology Committee of the Canadian Nosocomial Infection Surveillance Program, Health Canada (2004). Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother 48, 1204-1214.
28. Oteo, J., Navarro, C., Cercenado, E., Delgado-Iribarren, A., Wilhelmi, I., Orden, B., García, C., Miguelañez, S., Pérez- Vázquez, M. & other authors (2006). Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 44, 2359-2366.
29. Poirel, L., Naas, T., Le Thomas, I., Karim, A., Bingen, E. & Nordmann, P. (2001). CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother 45, 3355-3361. (Pubitemid 33107846)
30. Stepanova, M. N., Pimkin, M., Nikulin, A. A., Kozyreva, V. K., Agapova, E. D. & Edelstein, M. V. (2008). Convergent in vivo and in vitro selection of ceftazidime resistance mutations at position 167 of CTX-M-3 beta-lactamase in hypermutable Escherichia coli strains. Antimicrob Agents Chemother 52, 1297-1301.
31. Weill, F. X., Demartin, M., Tandé, D., Espié, E., Rakotoarivony, I. & Grimont, P. A. (2004). SHV-12-like extended-spectrum- beta-lactamase-producing strains of Salmonella enterica serotypes Babelsberg and Enteritidis isolated in France among infants adopted from Mali. J Clin Microbiol 42, 2432-2437. (Pubitemid 38747485)
32. Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M. & other authors (2004). Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 54, 735-743.